Market revenue in 2022 | USD 275.7 million |
Market revenue in 2030 | USD 369.5 million |
Growth rate | 3.7% (CAGR from 2022 to 2030) |
Largest segment | Viscosupplements |
Fastest growing segment | Synthetic |
Historical data | 2016 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Allografts, Synthetic, Cell-based, Viscosupplements |
Key market players worldwide | Anika Therapeutics Inc, Vericel Corp, Baxter International Inc, Zimmer Biomet Holdings Inc, Stryker Corp, Smith & Nephew PLC, BioTissue, MiMedx Group Inc, Arthrex, AlloSource, VSY Biotechnology, Aptissen |
Key Regions: Brazil , U.S. , UK , Japan , South Africa
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic regenerative surgical products market will help companies and investors design strategic landscapes.
Viscosupplements was the largest segment with a revenue share of 41.39% in 2022. Horizon Databook has segmented the Germany orthopedic regenerative surgical products market based on allografts, synthetic, cell-based, viscosupplements covering the revenue growth of each sub-segment from 2016 to 2030.
Presence of a large geriatric population and high prevalence of osteoarthritis in the country are among factors expected to drive market growth in the country. Thus, Germany dominated the European region. Owing to aging population, the prevalence of osteoarthritis in the country is anticipated to grow further in the near future.
As per MVZ Gelenk-Klinik Orthopaedic Clinic, over 24,000 orthopedic patients are treated every year and over 2,400 surgical procedures are performed annually in Germany. Germany is an attractive market owing to its constant growth and sophisticated healthcare infrastructure.
VSY Biotechnology GmbH is a privately held company active in ophthalmology and orthopedics markets. The company opened a new logistics facility in the country to streamline operations and supply chain in the European region. Hence, such initiatives promote the country’s market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany orthopedic regenerative surgical products market , including forecasts for subscribers. This country databook contains high-level insights into Germany orthopedic regenerative surgical products market from 2016 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account